NCT03962543 2026-04-08ReNeuSpringWorks Therapeutics, Inc.Phase 2 Active not recruiting114 enrolled 25 charts 3 FDA
NCT05891847 2025-06-10Non-interventional Study of Patients With PN NF1 Starting Selumetinib in RussiaAstraZenecaActive not recruiting150 enrolled